Phreesia, Inc. (PHR)
Stock Price:
$29.14 USD
1.15 (4.11%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
1.10B |
| Revenue (ttm) |
129.87M |
| Net Income (ttm) |
-19.71M |
| Shares Out |
37.68M |
| EPS (ttm) |
-2.85 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Jul 2, 2020 |
| Last Price |
$29.14 |
| Previous Close |
$27.99 |
| Change ($) |
1.15 |
| Change (%) |
4.11% |
| Day's Open |
28.49 |
| Day's Range |
28.08 - 29.14 |
| Day's Volume |
686,756 |
| 52-Week Range |
16.01 - 34.85 |
More Stats
| Market Cap |
1.10B |
| Enterprise Value |
1.03B |
| Earnings Date (est) |
Sep 14, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
37.68M |
| Float |
26.73M |
| EPS (basic) |
-9.3 |
| EPS (diluted) |
-2.85 |
| FCF / Share |
-0.32 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
946,488 |
| Short Ratio |
2.01 |
| Short % of Float |
3.31% |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
8.45 |
| PB Ratio |
10.59 |
| Revenue |
129.87M |
| Operating Income |
-16.01M |
| Net Income |
-19.71M |
| Free Cash Flow |
-11.98M |
| Net Cash |
63.19M |
| Net Cash / Share |
1.68 |
| Gross Margin |
61.65% |
| Operating Margin |
-12.33% |
| Profit Margin |
-63.90% |
| FCF Margin |
-9.22% |
| ROA |
-8.72% |
| ROE |
-43.70% |
| ROIC |
-43.20% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (13)
| Buy |
10 |
| Overweight |
2 |
| Hold |
1 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$34.75*
(19.25% upside)
Low
31.0
Current: 29.14
High
40.0
Target: 34.75
*Average 12-month price target from 12 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 |
|---|
| Revenue | 125 | 99.89 | 79.83 |
| Revenue Growth | 24.92% | 25.12% | - |
| Gross Profit | 80.06 | 62.89 | 50.06 |
| Operating Income | -15.30 | -9.49 | -14.55 |
| Net Income | -20.29 | -15.06 | -18.19 |
| Shares Outstanding | 20.30 | 1.84 | 1.54 |
| Earnings Per Share | -4.50 | -24.53 | -24.81 |
| Operating Cash Flow | 0.83 | -2.13 | -11.14 |
| Capital Expenditures | -12.32 | -9.83 | -11.97 |
| Free Cash Flow | -11.49 | -11.96 | -23.11 |
| Cash & Equivalents | 90.32 | 1.54 | 10.50 |
| Total Debt | 23.86 | 32.29 | 22.93 |
| Net Cash / Debt | 66.45 | -30.74 | -12.43 |
| Assets | 159 | 59.26 | 57.14 |
| Liabilities | 56.89 | 63.75 | 48.53 |
| Book Value | 102 | -211 | -168 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Phreesia, Inc. |
| Country |
United States |
| Employees |
532 |
| CEO |
Chaim Indig |
Stock Information
| Ticker Symbol |
PHR |
| Stock Exchange |
New York Stock Exchange |
| Sector |
Healthcare |
| Industry |
Health Information Services |
| Unique Identifier |
NYSE: PHR |
Description
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments. It deploys its platform in a range of modalities, including through Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Stations that are on-site kiosks. The company's Phreesia Platform provides a registration solution to automate patient self-registration; patient activation solution enables providers to communicate with their patients through automated, tailored surveys, announcements, messaging, and targeted health campaigns; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; clinical support solution that collects clinical intake and PRO data for approximately 25 specialties; appointments solution for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. It serves patients, healthcare provider organizations, and life sciences companies. The company was founded in 2005 and is headquartered in New York, New York.